CompletedPHASE2, PHASE3NCT00272948

Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide

Studying Hepatic veno-occlusive disease

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: European Society for Blood and Marrow Transplantation
Principal Investigator: Selim Corbacioglu, MD
University of Ulm, Germany
Intervention: Defibrotide(drug)
Enrollment: 360 target
Eligibility: 18 years · All sexes
Timeline: 2005 – 2009

Study locations (30)

University Hospital, Graz, Austria
St Anna Kinderspital, Vienna, Austria
Inst. Gustave Roussy, Villejuif, France
University Hospital, Dresden, Germany
Klinik Kinder-Onkologie, Düsseldorf, Germany
Johann-Wolfgang Goethe Universität, Frankfurt, Germany
Universitätsspital Eppendorf, Hamburg, Germany
Medical School, Hanover, Germany
University Hospital, Heidelberg, Germany
Kinderklinik, Jena, Germany
Christian-Albrecht -University, Kiel, Germany
Kinderpoliklinik Uni, München, Germany
Poliklinik Kinderheilkunde, Münster, Germany
Universitätsspital, Tübingen, Germany
Our Lady's Hospital for Sick Children, Dublin, Ireland
+15 more locations on ClinicalTrials.gov

Collaborators

Jazz Pharmaceuticals · Deutsche Krebshilfe e.V., Bonn (Germany)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00272948 on ClinicalTrials.gov

Other trials for Hepatic veno-occlusive disease

Additional recruiting or active studies for the same condition.

See all trials for Hepatic veno-occlusive disease →

← Back to all trials